Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Statement of Comprehensive Income [Abstract]      
Revenues $ 113,671 $ 76,190 $ 38,178
Cost of revenues 46,899 26,353 18,042
Gross profit 66,772 49,837 20,136
Operating expenses:      
Research and development, net 15,919 9,583 11,997
Clinical operations 9,365 4,332 4,672
Sales and marketing 100,641 47,705 27,536
General and administrative 34,770 10,199 5,359
Total operating expenses 160,695 71,819 49,564
Operating loss 93,923 21,982 29,428
Financial (income) expense, net (31,228) 364 (350)
Loss before taxes on income 62,695 22,346 29,078
Taxes on income 47 24 8
Net loss 62,742 22,370 29,086
Other comprehensive income (loss) 0 0 0
Comprehensive loss $ 62,742 $ 22,370 $ 29,086
Net loss per share (1):      
Basic and diluted net loss per share [1] $ 0.72 $ 1.67 $ 2.29
Weighted average number of common shares used in computing basic and diluted net loss per share (1) [1] 86,775,948 13,359,350 12,721,426
[1] Prior period results have been adjusted to reflect the exchange of Old Talkspace’s common stock for Talkspace’s common stock at an exchange ratio of approximately 1.134140 in June 2021 as a result of the Business Combination. See Note 3, “Business Combination” in the notes to the consolidated financial statements for further details.